Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 2, 2024
Abstract
Cerebrovascular
impairment
still
represents
one
of
the
main
causes
death
worldwide
with
a
mortality
rate
5.5
million
per
year.
Furthermore,
disability
50%
surviving
patients
factor
both
high
social
impact
and
costs
for
long
periods
time
national
healthcare
systems.
For
these
reasons,
efficacious
clinical
treatment
suffering
brain
ischemic
stroke
is
medical
need.
To
this
aim,
liposome
nanomedicine
having
monosialic
ganglioside
type
1
(GM1)
between
its
constituent
bearing
OX26
(an
anti-transferrin
receptor
antibody)
was
prepared
by
entrapping
CDP-choline
(a
neurotrophic
drug)
(CDP-choline/OX26Lip),
characterized
tested
in
vivo
on
an
rat
model.
CDP-choline/OX26Lip
were
freeze
thaw
followed
extrusion
through
polycarbonate
filters,
thus
achieving
~80
nm
mean
size
homogeneous
distribution.
It
demonstrated
that
showed
suitable
stability
presence
human
serum.
also
pharmacokinetic
profile,
30.0±4.2
%
administered
dose
blood
stream
12
h
after
systemic
administration.
The
post-ischemic
therapeutic
effect
better
than
CDP-choline/Lip,
showing
significant
greater
survival
re-perfused
rats,
i.e.
96%
78%
8
days,
respectively.
significantly
decreased
peroxidation
almost
5-fold
compared
to
as
expressed
amount
conjugated
dienes,i.e.
13.9
±
1.1
3.1
0.8
mmol/mg
proteins,
increased
could
be
attributed
improved
accumulation
encapsulated
delivered
OX26-conjugated
GM1-liposomes.
Therefore,
may
represent
strategy
reassessment
line
option
events
caused
stroke,
responding
needs.
Journal of the American Chemical Society,
Journal Year:
2024,
Volume and Issue:
146(12), P. 8228 - 8241
Published: March 12, 2024
It
remains
a
tremendous
challenge
to
explore
effective
therapeutic
modalities
against
neuroblastoma,
lethal
cancer
of
the
sympathetic
nervous
system
with
poor
prognosis
and
disappointing
treatment
outcomes.
Considering
limitations
conventional
intrinsic
vulnerability
we
herein
develop
pioneering
sequential
catalytic
that
utilizes
lactate
oxidase
(LOx)/horseradish
peroxidase
(HRP)-loaded
amorphous
zinc
metal–organic
framework,
named
LOx/HRP-aZIF,
in
combination
3-indole-acetic
acid
(IAA)
prodrug.
On
basis
abnormal
accumulation
occurs
tumor
microenvironment,
cascade
reaction
LOx
HRP
consumes
endogenous
glutathione
reduced
form
nicotinamide
adenine
dinucleotide
achieve
first
stage
killing
cells
via
antioxidative
incapacitation
electron
transport
chain
interference.
Furthermore,
generation
reactive
oxygen
species
induced
by
IAA
through
bioorthogonal
catalysis
promotes
ferritin
degradation
lipid
peroxidation,
ultimately
provoking
self-enhanced
ferroptosis
positive
feedback
initiating
an
Fenton
reaction.
This
work
highlights
superiority
natural
enzyme-dependent
reaction,
offering
paradigm
for
synergistically
enzyme-based
metabolism-ferroptosis
anticancer
therapy.
Advanced NanoBiomed Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 23, 2025
Cancer
remains
a
leading
cause
of
mortality
and
morbidity
worldwide.
Consequently,
the
scientific
community
continues
to
pursue
improvements
in
diagnostic
methods
subsequent
treatments.
To
enhance
treatment
efficacy
reduce
probability
adverse
outcomes,
reliable
sensitive
are
essential.
A
potential
solution
may
lie
synergy
between
nanotechnology
optical
biosensors,
as
they
can
provide
exceptional
sensitivity
detection
disease
biomarkers.
This
review
focuses
on
fluorescent
DNA
probes
assembled
onto
metal
nanoparticles
for
cancer‐related
applications.
These
hybrid
biosensors
exhibit
remarkable
versatile
properties
enabling
signal
emission
by
orders
magnitude.
In
these
configurations,
metallic
particles
function
antennas
dyes,
significantly
increasing
their
photon
rates.
presents
novel
perspective
recent
advancements
cancer
diagnostics
utilizing
biosensors.
Current
methodologies
examined,
toward
elucidating
advantages
limitations.
The
subject
matter
is
critically
evaluated,
fundamental
concepts
explored
assess
most
promising
avenues
clinical
potentially
integrate
into
medical
practice
healthcare
near
future,
both
diagnosis
prognosis
cancer,
well
precision
(P4)
medicine.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(20), P. 20167 - 20178
Published: Oct. 6, 2023
The
formation
of
a
protein
corona,
where
proteins
spontaneously
adhere
to
the
surface
nanomaterials
in
biological
environments,
leads
changes
their
physicochemical
properties
and
subsequently
affects
intended
biomedical
functionalities.
Most
current
methods
study
corona
are
ensemble-averaging
either
require
fluorescent
labeling,
washing
steps,
or
only
applicable
specific
types
particles.
Here
we
introduce
real-time
all-optical
nanoparticle
analysis
by
scattering
microscopy
(RONAS)
track
full
serum,
at
single-particle
level,
without
any
labeling.
RONAS
uses
optical
enables
situ
tracking
adsorption
on
metallic
dielectric
nanoparticles
with
different
geometries
directly
blood
serum.
We
analyzed
adsorbed
mass,
affinity,
kinetics
single
particle
level.
While
there
is
high
degree
heterogeneity
from
particle,
predominant
factor
chemistry
rather
than
underlying
material
size.
offers
an
in-depth
understanding
mechanisms
related
coronas
and,
thus,
development
strategies
engineer
efficient
bionanomaterials.
Current Opinion in Biotechnology,
Journal Year:
2024,
Volume and Issue:
87, P. 103101 - 103101
Published: March 11, 2024
Upon
administration,
nanomedicines
adsorb
a
corona
of
endogenous
biomolecules
on
their
surface,
which
can
affect
nanomedicine
interactions
with
cells,
targeting,
and
efficacy.
While
strategies
to
reduce
protein
binding
are
available,
the
high
selectivity
adsorbed
is
enabling
novel
applications,
such
as
for
biomarker
discovery
rare
identification.
Additionally,
molecules
promote
specific
cell
receptors,
thus
conferring
new
targeting
capabilities.
This
has
been
reported
Onpattro,
lipid
nanoparticle
hepatocytes
via
apolipoproteins
in
its
corona.
Recently,
selective
organ-targeting
(SORT)
nanoparticles
have
proposed,
exploit
corona-mediated
deliver
outside
liver.
Strategies
seeding
engineering
emerging
increase
similar
mechanisms.
Drug Delivery and Translational Research,
Journal Year:
2024,
Volume and Issue:
14(10), P. 2771 - 2787
Published: March 13, 2024
Abstract
Cerebrovascular
impairment
represents
one
of
the
main
causes
death
worldwide
with
a
mortality
rate
5.5
million
per
year.
The
disability
50%
surviving
patients
has
high
social
impacts
and
costs
in
long
period
treatment
for
national
healthcare
systems.
For
these
reasons,
efficacious
clinical
patients,
brain
ischemic
stroke,
remains
medical
need.
To
this
aim,
liposome
nanomedicine,
monosialic
ganglioside
type
1
(GM1),
OX26
(an
anti-transferrin
receptor
antibody),
CDP-choline
(a
neurotrophic
drug)
(CDP-choline/OX26Lip)
was
prepared.
CDP-choline/OX26Lip
were
prepared
by
freeze
thaw
method
then
extruded
through
polycarbonate
filters,
to
have
narrow
size
distributed
liposomes
~80
nm.
stable
human
serum,
they
had
suitable
pharmacokinetic
properties,
30.0
±
4.2%
injected
drug
still
present
blood
stream
12
h
after
its
systemic
injection.
post-ischemic
therapeutic
effect
is
higher
than
CDP-choline/Lip,
thus
showing
significantly
survival
re-perfused
rats,
i.e.
96%
78%
8
days.
decreased
peroxidation
~5-times
compared
CDP-choline/Lip;
resulting
conjugated
dienes,
that
13.9
1.1
mmol/mg
proteins
CDP-choline/Lip
3.1
0.8
CDP-choline/OX26Lip.
increased
accumulation
GM1-liposomes
tissues
CDP-choline.
Therefore,
nanomedicine
may
represent
strategy
reassessment
treat
events
caused
respond
significant
Graphical
abstract
Chemical Society Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
We
discuss
here
the
in
situ
characterization
methods
for
unraveling
nanoparticle–protein
interactions,
highlighting
challenges
of
protein
corona
and
its
significance
nanomedicine
development
clinical
translation.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 10, 2024
The
availability
of
high-frequency,
real-time
measurements
the
concentrations
specific
metabolites
in
cell
culture
systems
will
enable
a
deeper
understanding
cellular
metabolism
and
facilitate
application
good
laboratory
practice
standards
protocols.
However,
currently
available
approaches
to
this
end
either
are
constrained
single-time-point
single-parameter
or
limited
range
detectable
analytes.
Electrochemical
aptamer-based
(EAB)
biosensors
have
demonstrated
utility
monitoring
analytes